• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Waystar Acquires AI-Powered Revenue Cycle Platform Recondo Technology

Share:

December 10, 2019

With new capabilities, improved data efficacy and a larger team, Waystar can help healthcare organizations consolidate vendors and capture more revenue

Waystar, a leading provider of revenue cycle technology, today announced the acquisition of Recondo Technology, a pioneer of innovative revenue cycle automation solutions powered by advanced robotic process automation (RPA) and other artificial intelligence technology allowing providers to be paid more, faster and at lower cost. Waystar’s cloud-based technology simplifies and unifies the revenue cycle so that providers can redirect their resources to patient and community care. The two companies’ goals and technologies complement one another, making this an advantageous next step for both entities—and for the clients they serve.

Recondo brings additional artificial intelligence and machine learning technologies to Waystar’s broad portfolio of solutions. The capabilities include patient access technology that addresses inefficiencies surrounding price transparency, eligibility and pre-authorization processes, as well as business office technology that automates status checks for outstanding claims, reducing manual work. Merging Recondo and Waystar’s data will drive heightened accuracy and speed for all solutions, such as increasing the rate at which providers can determine if a patient has insurance coverage or send a prior authorization to a payer.

“Recondo shares Waystar’s commitment to helping healthcare organizations take the estimated $350 billion of administrative waste out of the revenue cycle,” said Matt Hawkins, CEO of Waystar. “Joining forces will strengthen our AI-powered offerings, which will in turn drive greater value for our clients and a better experience for patients. We have been impressed by the Recondo team and leadership, whose expertise and professionalism will be a strong addition to Waystar.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Founded in 2007, Recondo now processes nearly $4 billion in accurate patient estimates and 33 million prior authorizations annually as part of its patient access solution set. Waystar will unify the nearly half a billion administrative transactions processed by Recondo into the end-to-end Waystar platform, which will drive unprecedented insights and prevent issues before they occur. Incorporating these technologies will set the pace in the industry and transform the way patients understand and experience the financial side of their healthcare encounters.

“We were looking for a partner whose vision and capabilities would advance our goal of intelligently simplifying the revenue cycle, and Waystar fit this bill perfectly,” said Jay Deady, CEO of Recondo. “With Waystar’s powerful technology stack, talented team and client base, our technology can be more impactful than ever before.”

This announcement comes during a period of busy M&A and technology integration for Waystar, which most recently acquired Digitize.AI, an AI-powered prior authorization provider, and PARO, a financial assistance predictive analytics solution. In 2018, Waystar acquired predictive analytics solution Connance and claims monitoring capabilities from UPMC’s Ovation. All of these companies and technologies are being truly integrated into the market-leading Waystar platform to simplify payer and patient reimbursement and provide transformative solutions for healthcare providers.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc., a leading innovator of genomics for dermatology and non-invasive skin cancer diagnosisConstellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc., a leading innovator of genomics for dermatology and non-invasive skin cancer diagnosis
  • Healthcare M&A off to a fast start in the first quarterHealthcare M&A off to a fast start in the first quarter
  • Starboard drops out of Celgene fight as proxy firms back Bristol bidStarboard drops out of Celgene fight as proxy firms back Bristol bid
  • Pharmaceutical Cartridges Market Analysis and Key TrendsPharmaceutical Cartridges Market Analysis and Key Trends
  • Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor SystemsGetinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems
  • Pharma Sees More Post-M&A Rebrands Than Other Industries – and It Does Them Better, tooPharma Sees More Post-M&A Rebrands Than Other Industries – and It Does Them Better, too
  • Best Buy Health Now Offers Lively Health & Safety Services On Apple Watch For First TimeBest Buy Health Now Offers Lively Health & Safety Services On Apple Watch For First Time
  • Wealthcraft Capital Repositions Its Strategy in Response to the 2018 Farm BillWealthcraft Capital Repositions Its Strategy in Response to the 2018 Farm Bill

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications